Xiao Ma

2.2k total citations · 1 hit paper
95 papers, 1.4k citations indexed

About

Xiao Ma is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Xiao Ma has authored 95 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hematology, 25 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Xiao Ma's work include Hematopoietic Stem Cell Transplantation (35 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (14 papers). Xiao Ma is often cited by papers focused on Hematopoietic Stem Cell Transplantation (35 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (14 papers). Xiao Ma collaborates with scholars based in China, United States and United Kingdom. Xiao Ma's co-authors include Depei Wu, Xiao‐Jun Huang, Lan‐Ping Xu, Yu Wang, Kai‐Yan Liu, Xiaohui Zhang, Qifa Liu, Zhiping Fan, Xiaojin Wu and Depei Wu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Xiao Ma

84 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

2015 336 citations Yu Wang, Qifa Liu et al. profile →

Peers

Countries citing papers authored by Xiao Ma

Since Specialization

Citations

This map shows the geographic impact of Xiao Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Ma more than expected).

Fields of papers citing papers by Xiao Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Ma. The network helps show where Xiao Ma may publish in the future.

Co-authorship network of co-authors of Xiao Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Ma. A scholar is included among the top collaborators of Xiao Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Ma. Xiao Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut microbiota characteristics in neonatal respiratory distress syndrome and the therapeutic potential of probiotics in recovery 2025 ·Frontiers in Microbiology ·(unknown), Xiujuan Wang, (unknown), Zhaorui Wang, Xiao Ma, (unknown), Liping Han, Wenjun Fu, (unknown), Hongyan Ren, Da Zhang, Juan Ding	0
2	The synergistic antitumour effect of Carrimycin combined with 5-fluorouracil on colorectal cancer 2025 ·Scientific Reports ·Chao Shi, Xiao Ma, Ruixue Zhang, Zhenhua Lin, (unknown)	0
3	Increased colorectal cancer risk in prediabetes: A meta-analysis 2025 ·World Journal of Diabetes ·Na Wang, Tianyi Zhao, Xiao Ma	0
4	Applications of cell penetrating peptide-based drug delivery system in immunotherapy 2025 ·Frontiers in Immunology ·Jingjing Du, Ruyan Zhang, (unknown), Shanshan Xiao, Yiting Liu, (unknown), (unknown), Dongyuan Wang, Xiao Ma	8
5	Faculty standardized patients versus traditional teaching method to improve clinical competence among traditional Chinese medicine students: a prospective randomized controlled trial 2024 ·BMC Medical Education ·Meilan Huang, (unknown), Jing Guo, (unknown), (unknown), (unknown), Shan Zhou, Ting Xia, Sihan Peng, Lijuan Wen, Xiao Ma, (unknown), Jinhao Zeng	5
6	Low-dose emapalumab combined with chemotherapy for adult patients with Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis 2024 ·Transplant Immunology ·(unknown), Fei Zhou, Yue Song, Shiyuan Zhou, Feng Du, Qian Zhu, Ziyi Wang, (unknown), Jianhong Fu, Xiao Ma, Xingrong Wu, (unknown)	1
7	Conditioning therapy with N‐acetyl‐L‐cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation 2023 ·American Journal of Hematology ·Yaqiong Tang, Ziyan Zhang, Silu Liu, (unknown), Tingting Pan, Jiaqian Qi, (unknown), Yuejun Liu, (unknown), Meng Zhou, Xuefeng He, Xiaohui Hu, Xiao Ma, Depei Wu, Yue Han	4
8	Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999–2018 2023 ·Diabetes and Vascular Disease Research ·Yi Zhang, (unknown), Jian Wang, (unknown), Xiao Ma	1
9	Distinguishable Influence of the Delivery Mode, Feeding Pattern, and Infant Sex on Dynamic Alterations in the Intestinal Microbiota in the First Year of Life 2023 ·Microbial Ecology ·Xiao Ma, Juan Ding, Hongyan Ren, Xin Qi, Zhen Li, Liping Han, (unknown), (unknown), Chao Liu, Zhigang Ren	10
10	Safety and efficacy of different doses of anthracyclines combined with arsenic trioxide and all-trans retinoic acid in the treatment of de novo acute promyelocytic leukemia 2021 ·Hematology ·(unknown), Ke Peng, Haixia Zhou, Depei Wu, Suning Chen, Huiying Qiu, Yue Han, Caixia Li, Xiao Ma, (unknown), Xiaowen Tang, Xiaohui Hu	2
11	Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease 2021 ·Frontiers in Immunology ·Dong Wang, Yin Liu, (unknown), Jia Chen, Qiao Cheng, Xiao Ma, Zhihong Lin, Depei Wu, Yang Xu	13
12	Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience 2021 ·Haematologica ·(unknown), Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu, Ying Wang	2
13	PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation 2020 ·Bone Marrow Transplantation ·Chongsheng Qian, Xiao Ma, Jin Wang, (unknown), (unknown), Haixia Zhou, Mingzhu Xu, Aining Sun, Depei Wu, Songbai Liu, Shengli Xue	4
14	The impacts of acid suppression on duodenal microbiota during the early phase of severe acute pancreatitis 2020 ·Scientific Reports ·Xiao Ma, Libin Huang, Zhiyin Huang, (unknown), Chong Zhao, Huan Tong, Zhe Feng, Jinhang Gao, Rui Liu, Mingguang Zhang, Ming Zhou, (unknown), Ling Liu, Chengwei Tang	9
15	Clinical Features of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation Combined with Infusion of a Cord Blood 2019 ·Stem Cells and Development ·Tao Tao, Zheng Li, (unknown), Wenjuan Zhu, Yang Xu, Depei Wu, Xiao Ma, Shengli Xue	4
16	Video-assisted thoracoscopic surgery for invasive pulmonary fungal infection in haematology patients 2019 ·Journal of Thoracic Disease ·Han Ma, Jun Wang, Xiao Ma, (unknown), Haitao Ma, (unknown)	1
17	Ultrasonic/CT image fusion guidance facilitating percutaneous catheter drainage in treatment of acute pancreatitis complicated with infected walled-off necrosis 2018 ·Pancreatology ·Hui Zhang, Guangyu Chen, Le Xiao, Xiao Ma, Li Shi, Tao Wang, Hong-tao Yan, (unknown), (unknown), Lijun Tang, Weihui Liu	10
18	Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation 2017 ·Annals of Hematology ·Jiaqian Qi, Jie Wang, Chen Jia, Jian Su, Yaqiong Tang, Xiaojin Wu, Xiao Ma, Feng Chen, Changgeng Ruan, X. Long Zheng, Depei Wu, Yue Han	47
19	Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study 2016 ·Clinical Cancer Research ·Yu Wang, Qifa Liu, Lan‐Ping Xu, Kai‐Yan Liu, Xiaohui Zhang, Xiao Ma, Meiqing Wu, Depei Wu, Xiao‐Jun Huang	115
20	Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia 2014 ·Biology of Blood and Marrow Transplantation ·Ling Ge, (unknown), Xinliang Mao, Jia Chen, Aining Sun, Xiaming Zhu, Huiying Qiu, Zhengming Jin, Miao Miao, Chengcheng Fu, Xiao Ma, Feng Chen, Shengli Xue, Changgeng Ruan, Depei Wu, Xiaowen Tang	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact